Can Pelvic Radiotherapy Be Omitted in Select Patients With Rectal Cancer?

Seminars in Oncology

Volumn 33, Issue SUPPL. 11, 2006, Pages 70-74

  Lai, Lily L ^a   Fuller, Clifton D ^b,d   Kachnic, Lisa A ^c   Thomas Jr , Charles R ^d  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER PATIENT; EXCISION; HUMAN; LYMPH NODE DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECTUM CANCER; TUMOR LOCALIZATION; ULTRASOUND;

HUMANS; PELVIS; RECTAL NEOPLASMS;

EID: 33845381097     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.10.019     Document Type: Article

References (41)

1. Steele Jr. G.D., Herndon J.E., Bleday R., et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 6 (1999) 433-441
2. Gunderson L.L., and Sosin H. Areas of failure found at reoperation (second or symptomatic look) following curative surgery for adenocarcinoma of the rectum: Clinicopathologic correlation and implications for adjuvant therapy. Cancer 34 (1974) 1278-1292
3. Cedermark B., Johansson H., Rutqvist L.E., et al. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma: A prospective randomized trial. Cancer 75 (1995) 2269-2275
4. Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma: A prospective randomized trial. Cancer 66 (1990) 49-55
5. Balslev I.B., Pedersen M., Teglbjaerg P.S., et al. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study. Cancer 58 (1986) 22-28
6. Swedish Rectal Cancer Trial. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg 80 (1993) 1333-1336
7. Tepper J.E., O'Connell M.J., Petroni G.R., et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 15 (1997) 2030-2039
8. Pollack J., Holm T., Cedermark B., et al. Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum 49 (2006) 345-352
9. Enker W.E., Merchant N., Cohen A.M., et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg 230 (1999) 544-554
10. Lundby L., Krogh K., Jensen V.J., et al. Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Dis Colon Rectum 48 (2005) 1349-1352
11. Heriot A.G., Tekkis P.P., Fazio V.W., et al. Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model. Ann Surg 242 (2005) 502-511
12. Tepper J.E., O'Connell M., Niedzwiecki D., et al. Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control-Final report of Intergroup 0114. J Clin Oncol 20 (2002) 1744-1750
13. Gunderson L.L., Sargent D.J., Tepper J.E., et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol 22 (2004) 1785-1796
14. Willett C., Badizadegan K., Ancukiewicz M., et al. Prognostic factors in stage T2NO rectal cancer. Dis Colon Rectum 42 (1999) 167-173
15. Lopez-Kostner F., Lavery I.C., Hool G.R., et al. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 124 (1998) 612-618
16. Faerden A.E., Naimy N., Wiik P., et al. Total mesorectal excision for rectal cancer: Differences in outcome for low and high rectal cancer. Dis Colon Rectum 48 (2005) 2224-2231
17. Folkesson J., Birgisson H., Pahlman L., et al. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23 (2005) 5644-5650
18. Lee S.H., Hernandez de Anda E., Finne C.O., et al. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Dis Colon Rectum 48 (2005) 2249-2257
19. Massari M., De Simone M., Cioffi U., et al. Value and limits of endorectal ultrasonography for preoperative staging of rectal carcinoma. Surg Laparosc Endosc 8 (1998) 434-444
20. Herzog U., von Flue M., Tondelli P., et al. How accurate is endorectal ultrasound in the preoperative staging of rectal cancer?. Dis Colon Rectum 36 (1993) 127-134
21. Kim H.J., and Wong W.D. Role of endorectal ultrasound in the conservative management of rectal cancers. Semin Surg Oncol 19 (2000) 358-366
22. Schaffzin D., and Wong W.D. Endorectal ultrasound in the preoperative evaluation of rectal cancer. Clin Colorectal Cancer 4 (2004) 124-132
23. Daniels I., and MERCURY Study Group. MRI accurately predicts the CRM status of rectal cancer in a multicentre multidisciplinary European study. Proceedings of American Society of Colon and Rectal Surgeons Annual Meeting. Dis Colon Rectum 48 (2005) 100
24. Heald R.J., and Ryall R. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1 (1986) 1479-1482
25. Enker W.E., Thaler H.T., Cranor M.L., et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181 (1995) 335-346
26. Havenga K., Enker W.E., McDermott K., et al. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 182 (1996) 495-502
27. Arbman G., Nilsson E., Hallbook O., et al. Local recurrence following total mesorectal excision for rectal cancer. Br J Cancer 83 (1996) 375-379
28. Kockerling F., Reymond M.A., Altendorf-Hofmann A., et al. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 16 (1998) 324-329
29. Arenas R.B., Fichera A., Mhoon D., et al. Total mesenteric excision in the surgical treatment of rectal cancer. Arch Surg 133 (1998) 608-612
30. Garcia-Granero E., et al. Local recurrence in TME surgery without preoperative chemoradiation. Is the circumferential resection margin involvement an important prognostic factor. Proceedings of the 2005 American Society of ColoRectal Surgeons Annual Meeting. Dis Colon Rectum 48 (2005) 113
31. Pocard M., Panis Y., Malassagne B., et al. Assessing the effectiveness of the mesorectal excision in rectal cancer: prognostic value of the number of lymph nodes found in resected specimens. Dis Colon Rectum 41 (1998) 839-845
32. Gastrointestinal Tumors Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312 (1985) 1465-1472
33. Gerard A., Buyse M., Nordlinger B., et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer: Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 208 (1988) 606-614
34. Fisher B., Wolmark N., Rockette H., et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP Protocol R-01. J Natl Cancer Inst 80 (1988) 21-29
35. Pahlman L., and Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma: Report from a randomized multicenter trial. Ann Surg 211 (1990) 187-195
36. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 324 (1991) 709-715
37. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336 (1997) 980-987
38. Wolmark N., Wieand H.S., Hyams D.M., et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92 (2000) 388-396
39. Quirke P., Durdey P., Dixon M.F., et al. Local recurrence of rectal adenocarcinoma due to adequate surgical resection: Histopathological study of lateral tumour spread and surgical excision. Lancet 2 (1986) 996-999
40. Adam I.J., Mohamdee M.O., Martin I.G., et al. Role of circumferential margin involvement in local recurrence of rectal cancer. Lancet 344 (1994) 707-711
41. Hall N.R., Finan P.J., al-Jaberi T., et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent: predictor of survival but not local recurrence?. Dis Colon Rectum 41 (1998) 979-983